On December 15th, 2020, Dr. Jonathan Nakashima, PhD, CSO of Certis Oncology, joined Taconic Biosciences to present a comprehensive overview of O-PDX testing. O-PDX is a technique which uses in vivo pharmacology testing in personalized mouse models, and can accurately predict a tumor’s response to multiple therapies, as well as cancer recurrence, metastases and drug resistance.
Download a copy of the presentation here: Certis Oncology - Orthoptopic-PDX Models
